John D. Reveille

Active 1983–2025

Also published as
John D Reveille
210
Papers
36,818
Citations
111
h-index
209
i10-index

Citations

Citations per year for John D. Reveille1982: 1 citations1984: 4 citations1985: 2 citations1986: 8 citations1987: 4 citations1989: 5 citations1990: 9 citations1991: 12 citations1992: 23 citations1993: 11 citations1994: 25 citations1995: 34 citations1996: 37 citations1997: 21 citations1998: 58 citations1999: 61 citations2000: 58 citations2001: 49 citations2002: 84 citations2003: 99 citations2004: 111 citations2005: 119 citations2006: 195 citations2007: 181 citations2008: 174 citations2009: 284 citations2010: 295 citations2011: 341 citations2012: 363 citations2013: 373 citations2014: 340 citations2015: 421 citations2016: 356 citations2017: 310 citations2018: 340 citations2019: 1,188 citations2020: 1,146 citations2021: 938 citations2022: 766 citations2023: 508 citations2024: 689 citations2025: 256 citations2026: 2 citations1983: no citations, so this year is not shown1988: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,214 citing papers, 23.8% of this breakdownUnited Kingdom: 1,155 citing papers, 8.6% of this breakdownChina: 764 citing papers, 5.7% of this breakdownGermany: 760 citing papers, 5.6% of this breakdownItaly: 611 citing papers, 4.5% of this breakdownCanada: 610 citing papers, 4.5% of this breakdownFrance: 568 citing papers, 4.2% of this breakdownNetherlands: 561 citing papers, 4.2% of this breakdownSpain: 434 citing papers, 3.2% of this breakdownAustralia: 387 citing papers, 2.9% of this breakdownJapan: 336 citing papers, 2.5% of this breakdownSweden: 312 citing papers, 2.3% of this breakdown
0%23.8%Other 28%

Fields

  • Medicine77%
  • Biochemistry, Genetics and Molecular Biology10.3%
  • Immunology and Microbiology9.8%
  • Health Professions0.6%
  • Neuroscience0.5%
  • Computer Science0.3%
  • Other1.5%

Topics

  • Systemic Lupus Erythematosus Research10.2%
  • Rheumatoid Arthritis Research and Therapies8%
  • Spondyloarthritis Studies and Treatments7.4%
  • Systemic Sclerosis and Related Diseases4.6%
  • T-cell and B-cell Immunology3.2%
  • Psoriasis: Treatment and Pathogenesis2.8%
  • Other63.8%

Coauthors

All papers

Open in search
  1. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 1,563

  2. Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Benedicte A Lie, Øystein Førre, Jaakko Tuomilehto, Kari Laiho, Lei Jiang, Yu Liu, Xin Wu, Huji Xu, Dirk Elewaut, Ruben Burgos-Vargas, Simon Stebbings, Nigil Haroon, Robert D Inman, Manuel A Ferreira, Juan Mulero, Jose Luis Fernandez-Sueiro, Miguel A Gonzalez-Gay, Carlos Lopez-Larrea, Panos Deloukas, Peter Donnelly, Karl Gafney, Hill Gaston, Dafna D Gladman, Proton Rahman, Walter P Maksymowych, J Bart A Crusius, Irene E van der Horst-Bruinsma, Chung-Tei Chou, Raphael Valle-Oñate, Consuelo Romero-Sánchez, Inger Myrnes Hansen, Fernando M Pimentel-Santos, Vibeke Videm, Javier Martin, David M Evans - Nature Genetics 2013 cited by 873

  3. Transancestral mapping and genetic load in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeffrey C. Edberg, Emõke Endreffy, Jorge Antonio Esquivel‐Valerio, Paul R. Fortin, Barry I. Freedman, Johan Frostegård, Mercedes García, Ignacio García‐De La Torre, Gary S. Gilkeson, Dafna D. Gladman, Iva Gunnarsson, Joel M. Guthridge, Jennifer L. Huggins, Judith A. James, Cees G. M. Kallenberg, Diane L. Kamen, David R. Karp, Kenneth M. Kaufman, Leah C. Kottyan, László Kovács, Helle Laustrup, Bernard Lauwerys, Quan‐Zhen Li, Marco A. Maradiaga‐Ceceña, Javier Martı́n, Joseph M. McCune, David R. McWilliams, Joan T. Merrill, Pedro C. Miranda, J. F. Moctezuma, Swapan K. Nath, Timothy B. Niewold, Lorena Orozco, Norberto Ortego‐Centeno, Michelle Petri, Christian A. Pineau, Bernardo A. Pons‐Estel, Janet Pope, Prithvi Raj, Rosalind Ramsey‐Goldman, John D. Reveille, Laurie Russell, José Mario Sabio, Carlos A. Aguilar‐Salinas, Hugo R. Scherbarth, R Scorza, Michael F. Seldin, Christopher Sjöwall, Elisabet Svenungsson, Susan D. Thompson, Sergio Toloza, Lennart Truedsson, Teresa Tusié‐Luna, Carlos Vasconcelos, Luis M. Vilá, Daniel J. Wallace, Michael H. Weisman, Joan Wither, Tushar Bhangale, Jorge R. Oksenberg, John D. Rioux, Peter K. Gregersen, Ann‐Christine Syvänen, Lars Rönnblom, Lindsey A. Criswell, Chaim O. Jacob, Kathy L. Sivils, Betty P. Tsao, Laura E. Schanberg, Timothy W. Behrens and 8 more - Nature Communications 2017 cited by 437

  4. Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leo A. B. Joosten, Vanessa Smith, Filip De Keyser, Rafaella Scorza, C. Lunardi, Piet L. C. M. van Riel, Madelon C Vonk, Waander L. van Heerde, Stephan Meller, Bernhard Homey, Lorenzo Beretta, Mark Roest, Maria Trojanowska, Robert Lafyatis, Timothy R. D. J. Radstake - New England Journal of Medicine 2013 cited by 454

  5. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I

    Authors: , , , , , , , , , , , , , - Arthritis & Rheumatism 2007 cited by 2,077

  6. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: Support for the notion of a gene‐dose effect from the X chromosome

    Authors: , , , , , , , , , , , , , - Arthritis & Rheumatism 2008 cited by 419

  7. Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 104

  8. Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , J. S. Hill Gaston, Malcolm Smith, Jácome Bruges‐Armas, Ana Rita Couto, Rosa Sorrentino, Fabiana Paladini, Manuel A. R. Ferreira, Huji Xu, Yu Liu, Lei Jiang, Carlos López‐Larrea, Roberto Díaz‐Peña, Antonio López‐Vázquez, Tetyana Zayats, Gavin Band, Céline Bellenguez, Hannah Blackburn, Jenefer M. Blackwell, Elvira Bramon, Suzannah J. Bumpstead, Juan Pablo Casas, Aiden Corvin, Nicholas Craddock, Panos Deloukas, Serge Dronov, Audrey Duncanson, Sarah Edkins, Colin Freeman, Matthew Gillman, Emma Gray, Rhian Gwilliam, Naomi Hammond, Sarah Hunt, Janusz Jankowski, Alagurevathi Jayakumar, Cordelia Langford, Jennifer Liddle, Hugh S. Markus, Christopher G. Mathew, Owen T McCann, Mark I. McCarthy, Colin N A Palmer, Leena Peltonen, Robert Plomin, Simon Potter, Anna Rautanen, Rathi Ravindrarajah, Michelle Ricketts, Nilesh J. Samani, Stephen Sawcer, Amy Strange, Richard C. Trembath, Ananth C. Viswanathan, Matthew Waller, Paul A. Weston, Pamela Whittaker, Sara Widaa, Nicholas Wood, Gil McVean, John D. Reveille, B P Wordsworth, Matthew A. Brown, Peter Donnelly - Nature Genetics 2011 cited by 907

  9. Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frédéric Morin, Proton Rahman, Aaron Alejandro Barrera Rodriguez, Fidencio Cons-Molina, Sergio Duran Barragan, Cassandra M. Skinner, César Pacheco‐Tena, César Ramos-Remus, Juan Cruz Rizo Rodriguez, Seung-Jae Hong, Yeon-Ah Lee, Ji Hyeon Ju, Seong Wook Kang, Tae‐Hwan Kim, Chang Keun Lee, Eun Bong Lee, Sang Heon Lee, Min‐Chan Park, Kichul Shin, Sang‐Hoon Lee, Hung-An Chen, Ying‐Chou Chen, Song‐Chou Hsieh, Joung‐Liang Lan, Zdeněk Dvořák, Radka Moravcová, Martina Malcova, Yoshinori Taniguchi, Mitsumasa Kishimoto, Kurisu Tada, Hiroaki Dobashi, Kentaro Inui, Yukitaka Ueki, Yoshifuji Matsumoto, Yoshinobu Koyama, Kazuhiro Hatta, Tatsuya Atsumi, Midori Goto, Kiyoshi Matsui, Yuya Takakubo, Gunther Neeck, Denis Poddubnyy, Andrea Rubbert‐Roth, Malgorzata Szymańska, Tomasz Blicharski, Anna Dudek, Artur Racewicz, Rafał Wojciechowski, Marleen van de Sande, E. N. Griep, Mike Nurmohamed, Galina Matsievskaya, Е. Шмидт, Marina Stanislav, S. S. Yakushin, О. Б. Ершова, А. П. Ребров, Tibor Balázs, Regina Cseuz, Edit Drescher, Gyula Poór - The Lancet 2018 cited by 359

  10. Ankylosing spondylitis risk factors: a systematic literature review

    Authors: , , - Clinical Rheumatology 2021 cited by 156

  11. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael F. Seldin, Lars Rönnblom, Lindsey A. Criswell, Ann-Christine Syvänen, Timothy W. Behrens, Robert Graham - Nature Genetics 2009 cited by 809

  12. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double‐blind, placebo‐controlled trial

    Authors: , , , , , , , , , , - Arthritis & Rheumatism 2006 cited by 878

  13. End‐Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Joyce R. Byers, Anna K. Vinnikova, Janice P. Lea, Bruce A. Julian, Robert P. Kimberly - Arthritis & Rheumatology 2013 cited by 297

  14. Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors

    Authors: , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2018 cited by 233

  15. Development of a health index in patients with ankylosing spondylitis (ASAS HI): final result of a global initiative based on the ICF guided by ASAS

    Authors: , , , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 227

  16. American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatology 2015 cited by 549

  17. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

    Authors: , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2013 cited by 468

  18. Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort

    Authors: , , , , , , , - Arthritis Care & Research 2009 cited by 309

  19. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis

    Authors: , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 108

  20. A missense mutation in the MLKL brace region promotes lethal neonatal inflammation and hematopoietic dysfunction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Marc Pellegrini, Gillian M. Tannahill, Esme C. Hatchell, Tracy A. Willson, Dina Stockwell, Carolyn A. de Graaf, Janelle E. Collinge, Adrienne A. Hilton, Natasha Silke, Sukhdeep K. Spall, Diep Chau, Vicki Athanasopoulos, Donald Metcalf, Ronald M. Laxer, Alexander G. Bassuk, Benjamin W. Darbro, Maria A. Fiatarone Singh, Nicole Vlahovich, David Hughes, Maria Kozlovskaia, David B. Ascher, Klaus Warnatz, Nils Venhoff, Jens Thiel, Christine Biben, Stefan Blum, John D. Reveille, Michael S. Hildebrand, Carola G. Vinuesa, Pamela McCombe, Matthew A. Brown, Benjamin T. Kile, Catriona McLean, Melanie Bahlo, Seth L. Masters, Hiroyasu Nakano, Polly J. Ferguson, James M. Murphy, Warren S. Alexander, John Silke - Nature Communications 2020 cited by 95

  21. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.

    Authors: , , , , , - 2004 cited by 228

  22. Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as Susceptibility Loci for Systemic Lupus Erythematosus in a Large-Scale Multiracial Replication Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Judith A. James, Diane L. Kamen, Robert P. Kimberly, Jae‐Hoon Kim, Javier Martı́n, Joan T. Merrill, Timothy B. Niewold, So Yeon Park, Michelle Petri, Bernardo A. Pons‐Estel, Rosalind Ramsey‐Goldman, John D. Reveille, R. Hal Scofield, Yeong Wook Song, Anne M. Stevens, Betty P. Tsao, Luis M. Vilá, Timothy J. Vyse, C. Yung Yu, Joel M. Guthridge, Kenneth M. Kaufman, John B. Harley, Edward K. Wakeland, Carl D. Langefeld, Patrick M. Gaffney, Courtney G. Montgomery, Kathy L. Moser - The American Journal of Human Genetics 2012 cited by 186

  23. Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual

    Authors: , , , , , , , , , - Arthritis & Rheumatism 2005 cited by 384

  24. Epidemiology of Spondyloarthritis

    Authors: , , , - Rheumatic Disease Clinics of North America 2012 cited by 257